Dr. Nicolas Chomont is an assistant professor in the Department of Microbiology and Immunology at the Université de Montréal – CHUM Research Center. He obtained his PhD in medical virology at Pierre et Marie Curie University in Paris where he extensively studied the interactions between HIV and the genital mucosa.
Dr. Afam Okoye holds a Bachelors degree in Microbiology from University of Nigeria and a Master in Biotechnology from Nottingham Trent University, United Kingdom. He received his Ph.D. from the University of Glasgow studying papillomavirus capsid proteins under the mentorship of Prof. Saveria Campo.
Dr. Robert F. Siliciano is a Professor of Medicine and Molecular Biology and Genetics at the Johns Hopkins University School of Medicine and a member of the Howard Hughes Medical Institute. In 1995, his laboratory provided the first demonstration that latently infected memory CD4+ T cells were present in patients with HIV-1 infection.
Dr. Sarah Palmer is the Deputy Director of the Centre for Virus Research at The Westmead Institute for Medical Research and Associate Professor in the Faculty of Medicine at the University of Sydney. Prior to taking up this position in early 2013, she was a Senior Researcher at the Swedish Institute for Communicable Disease Control and Karolinska Institutet, in Stockholm, Sweden from 2008 to 2012.
Dr. Jake Estes obtained his Ph.D. at Brigham Young University in the laboratory of Dr. Gregory Burton studying the contributions of follicular dendritic cells and the germinal center microenvironment to HIV pathogenesis. Dr. Estes continued his work as a postdoctoral fellow in the laboratory of Dr. Ashley Haase in the Department of Microbiology at the University of Minnesota, focusing on the in vivo immunopathology of lentiviral infections in lymphoid tissues in both human patient cohorts and non-human primate models.
Dr. Daniel C. Douek studied medicine at the Universities of Oxford and London. He then practiced internal medicine, before pursuing a PhD in Immunology at the University of London. Dr. Douek was appointed to the NIH Vaccine Research Center in November 2000.